Thus, TMED2 may regulate the inflammatory response of lung adenocarcinoma through TLR4/NF-κB signaling and promote the proliferation, development, and prognosis of lung adenocarcinoma by regulating the inflammatory response, providing a new strategy for treatment of lung adenocarcinoma53. This evidence concerns the gene TMED2 and lung adenocarcinoma.